Division of Emergency Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Children's Hospital Colorado, Aurora.
JAMA Pediatr. 2022 Jul 1;176(7):672-678. doi: 10.1001/jamapediatrics.2022.1301.
Pediatric sepsis definitions have evolved, and some have proposed using the measure used in adults to quantify organ dysfunction, a Sequential Organ Failure Assessment (SOFA) score of 2 or more in the setting of suspected infection. A pediatric adaptation of SOFA (pSOFA) showed excellent discrimination for mortality in critically ill children but has not been evaluated in an emergency department (ED) population.
To delineate test characteristics of the pSOFA score for predicting in-hospital mortality among (1) all patients and (2) patients with suspected infection treated in pediatric EDs.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study took place from January 1, 2012, to January 31, 2020 in 9 US children's hospitals included in the Pediatric Emergency Care Applied Research Network (PECARN) Registry. The data was analyzed from February 1, 2020, to April 18, 2022. All ED visits for patients younger than 18 years were included.
ED pSOFA score was assigned by summing maximum pSOFA organ dysfunction components during ED stay (each 0-4 points). In the subset with suspected infection, visit meeting criteria for sepsis (suspected infection with a pSOFA score of 2 or more) and septic shock (suspected infection with vasoactive infusion and serum lactate level >18.0 mg/dL) were identified.
Test characteristics of pSOFA scores of 2 or more during the ED stay for hospital mortality.
A total of 3 999 528 (female, 47.3%) ED visits were included. pSOFA scores ranged from 0 to 16, with 126 250 visits (3.2%) having a pSOFA score of 2 or more. pSOFA scores of 2 or more had sensitivity of 0.65 (95% CI, 0.62-0.67) and specificity of 0.97 (95% CI, 0.97-0.97), with negative predictive value of 1.0 (95% CI, 1.00-1.00) in predicting hospital mortality. Of 642 868 patients with suspected infection (16.1%), 42 992 (6.7%) met criteria for sepsis, and 374 (0.1%) met criteria for septic shock. Hospital mortality rates for suspected infection (599 502), sepsis (42 992), and septic shock (374) were 0.0%, 0.9%, and 8.0%, respectively. The pSOFA score had similar discrimination for hospital mortality in all ED visits (area under receiver operating characteristic curve, 0.81; 95% CI, 0.79-0.82) and the subset with suspected infection (area under receiver operating characteristic curve, 0.82; 95% CI, 0.80-0.84).
In a large, multicenter study of pediatric ED visits, a pSOFA score of 2 or more was uncommon and associated with increased hospital mortality yet had poor sensitivity as a screening tool for hospital mortality. Conversely, children with a pSOFA score of 2 or less were at very low risk of death, with high specificity and negative predictive value. Among patients with suspected infection, patients with pSOFA-defined septic shock demonstrated the highest mortality.
儿科脓毒症的定义已经发生了变化,有人建议使用成人中用于量化器官功能障碍的方法,即在疑似感染的情况下,序贯器官衰竭评估(SOFA)得分为 2 或更高。儿科 SOFA (pSOFA)的儿科适应性在重症儿童死亡率方面表现出了优异的判别力,但尚未在急诊科(ED)人群中进行评估。
描述 pSOFA 评分预测(1)所有患者和(2)在儿科 ED 接受疑似感染治疗的患者院内死亡率的试验特征。
设计、地点和参与者:本回顾性队列研究于 2012 年 1 月 1 日至 2020 年 1 月 31 日在包含于儿科急诊护理应用研究网络(PECARN)注册中的 9 家美国儿童医院进行。数据分析于 2020 年 2 月 1 日至 2022 年 4 月 18 日进行。所有年龄小于 18 岁的 ED 就诊均包括在内。
ED pSOFA 评分通过在 ED 期间(每个 0-4 分)累加最高 pSOFA 器官功能障碍成分来确定。在疑似感染的亚组中,确定符合脓毒症(疑似感染且 pSOFA 评分≥2)和感染性休克(疑似感染且血管活性药物输注和血清乳酸水平>18.0mg/dL)标准的就诊。
ED 期间 pSOFA 评分≥2 与医院死亡率的测试特征。
共纳入 3999528 例(女性占 47.3%)ED 就诊。pSOFA 评分范围从 0 到 16,其中 126250 例(3.2%)pSOFA 评分≥2。pSOFA 评分≥2 的敏感性为 0.65(95%CI,0.62-0.67),特异性为 0.97(95%CI,0.97-0.97),阴性预测值为 1.0(95%CI,1.00-1.00),用于预测医院死亡率。在 642868 例疑似感染患者中(16.1%),42992 例(6.7%)符合脓毒症标准,374 例(0.1%)符合感染性休克标准。疑似感染(599502 例)、脓毒症(42992 例)和感染性休克(374 例)的医院死亡率分别为 0.0%、0.9%和 8.0%。pSOFA 评分在所有 ED 就诊(接受者操作特征曲线下面积,0.81;95%CI,0.79-0.82)和疑似感染亚组(接受者操作特征曲线下面积,0.82;95%CI,0.80-0.84)中对医院死亡率的判别能力相似。
在一项针对儿科 ED 就诊的大型多中心研究中,pSOFA 评分≥2 并不常见,与医院死亡率增加相关,但作为医院死亡率的筛查工具,其敏感性较差。相反,pSOFA 评分<2 的儿童死亡风险非常低,特异性和阴性预测值较高。在疑似感染患者中,pSOFA 定义的感染性休克患者死亡率最高。